Does Warfarin Interact with Dextrose Soybean Oil Electrolytes Lysine Phenylalanine Leuci?
Warfarin and Dextrose Soybean Oil Electrolytes Lysine Phenylalanine Leuci have a major drug interaction according to U.S. FDA drug labeling data. Vitamin K1 in soybean oil component may reverse anticoagulant activity of warfarin. Monitor anticoagulant laboratory parameters. The mechanism involves vitamin k1 reverses warfarin's anticoagulant effect by facilitating vitamin k1 recycling. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Major
- Dextrose Soybean Oil Electrolytes Lysine Phenylalanine Leuci Class
- Amino Acid
- Management
- Close medical supervision required
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Warfarin and Dextrose Soybean Oil Electrolytes Lysine Phenylalanine Leuci occurs because vitamin k1 reverses warfarin's anticoagulant effect by facilitating vitamin k1 recycling. Clinically, this means vitamin k1 in soybean oil component may reverse anticoagulant activity of warfarin. monitor anticoagulant laboratory parameters. This is classified as a major interaction, meaning it could cause serious harm if not properly managed. Your healthcare provider may need to adjust dosages, substitute one medication, or increase monitoring frequency.
What To Tell Your Doctor or Pharmacist
If you are taking Warfarin and your doctor is considering prescribing Dextrose Soybean Oil Electrolytes Lysine Phenylalanine Leuci (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask how frequently you should be monitored while these are co-prescribed
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider